(STAG-TB) Members, 2020

Biographical Profiles of WHO Strategic and Technical Advisory Group for TB (STAG-TB) Members, 2020 STAG-TB Chair • Dr Ariel PABLOS-MÉNDEZ, National of USA and Mexico Professor of Medicine at Columbia University Medical Center, New York, USA Dr Ariel Pablos-Méndez is a physician, scholar, and diplomat in global health. Dr Pablos-Méndez began his public health career at Columbia University working on the emergence of MDR-TB in New York City in the early 1990s; he later led the Global Surveillance Project on Anti-Tuberculosis Drug Resistance at the World Health Organization (WHO). In both instances, his research and publications brought about significant and successful policy changes. He also served as Director of Knowledge Management at WHO in Geneva, creating WHO Press, working to bridge the know-do gap in public health and pioneering global e-Health. As program officer of The Rockefeller Foundation, Dr Pablos-Méndez spearheaded public-private partnerships in R&D for diseases of poverty (e.g. the Global Alliance for TB Drug Development which recently received FDA approval for Pretomanid), the Foundation's strategy on AIDS treatment in Africa, and the Joint Learning Initiative on Human Resources for Health. He returned to Rockefeller as Managing Director and led the Foundation’s initiative to position universal health coverage on the international agenda. Dr Pablos-Méndez was appointed by President Barack Obama, to lead the Global Health program of USAID, serving as Assistant Administrator for Global Health.. Dr Pablos-Méndez drove the vision to End Preventable Child and Maternal Deaths and contributed to catalysing an AIDS-Free Generation while supporting health systems strengthening, family planning and country ownership through initiatives such as The Global Financing Facility for Every Woman Every Child. He participated in the U.S. response to Ebola and Zika, and championed the Global Virome Project. Dr Pablos-Méndez received his M.D. from the University of Guadalajara (Mexico), and his M.P.H from Columbia University (New York), where he has been a Faculty member for over 20 years. He has over 150 publications and is a member of various boards and international commissions. Existing Members • Ms Jamilya Ismoilova, National of Tajikistan Ms Jamilya Ismoilova is a Public Health professional with over 20 years’ experience in planning, implementing and monitoring TB, MDR-TB and TB/HIV programs, as well as maternal and child health, community health, health promotion programs. Since 2004, Ms Jamilya has worked for the International NGO Project HOPE holding several positions including Regional ACSM/Community Engagement Advisor, during which time she provided strategic and technical guidance to Project HOPE TB/MDR-TB programs in Europe and the Eurasia region. For the last five years she has worked as the Country Director of Project HOPE Tajikistan, where she manages and oversees multiple TB Control projects funded by The Global Fund and USAID. Prior to Project HOPE, she worked with Mercy Corps, UNESCO and within the government health sector. Ms Jamilya is recognized for her Community Engagement, Advocacy, Communications and Social Mobilization (ACSM) expertise, as well as her background in Behaviour Change Communication 1 methodologies. She has been a member of the WHO Civil Society Task Force on TB. She graduated from Tajik State Medical College and Tajik State Pedagogical University, and has an MSc in Public Health from the London School of Hygiene and Tropical Medicine. • Dr Seiya Kato, National of Japan Dr Kato is a TB specialist, and was appointed as Director of the Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association (RIT/ JATA) in April 2017. Prior to this, he worked from 2006- 2017 as the Vice Director, and from 2003-2006 as the Head of Technical Support Division/ Head of Research Division, for RIT/ JATA. As a TB and public health specialist, Dr Kato serves as Chair of the Japanese Tuberculosis Committee, and is a member of the National Health Science Council, Ministry of Health, Labour and Welfare, Japan. He also serves as a member of the Executive Board of the Japanese Society for Tuberculosis and as Chair of its Prevention Committee. Dr Kato graduated from Sapporo Medical University, School of Medicine in 1981, and worked as a pulmonologist for 12 years, during which time he specialized in treating MDR-TB patients and those with HIV. He joined the Sapporo City Government as a medical officer in 1993 and worked for the public health centers and head office for over seven years. In 2000, he joined RIT/ JATA and was in the Philippines as the Chief Advisor for the JICA TB Control Project from 2000-2003. • Dr Ya Diul Mukadi National of the Democratic Republic of the Congo and United States of America Senior Medical Officer, USAID, Washington, United States of America. Dr Mukadi provides strategic guidance and technical assistance to USAID, host governments and partners in the design and implementation of innovative approaches and tools to control TB. This includes directing the planning and execution of clinical trials and operational research to improve the management of TB and latent TB infection. He manages the implementation of major grants focusing on TB research and drug development including research on the treatment of latent TB using novel TB drugs and regimens. He has previously worked for Family Health International, WHO, and UNAIDS. New STAG-TB Members • Dr Denise ARAKAKI, National of the Brazil Deputy Director of the Department of Chronic Communicable Diseases and Sexually-Transmitted Infections Secretariat of Health Surveillance, Ministry of Health, Brazil Dr Arakaki began her career as an infectious disease physician at the São Paulo State Secretariat of Health, in the Epidemiological Surveillance Group, and then served as a technical advisor to the Treatment Unit of the National STD/AIDS Program of the Ministry of Health. She then served as Program Director for the International Center for AIDS Care and Treatment Programs (ICAP) at the Mailman School of Public Health, Columbia University to expand access to antiretroviral treatment in Mozambique. Later, Dr Arakaki served as a technical advisor to Mozambique’s Ministry of Health's National Tuberculosis Control Program. For four years, she served as national consultant for tuberculosis at the Pan American Health Organization/World Health Organization Office in Brazil and then served in the Ministry of Health of the Federal District. In 2016, she became General Coordinator of the National Tuberculosis Control Program in Brazil, before assuming her current role in 2019. 2 She graduated in Medicine at School of Medicine of Universidade Estadual Paulista with a medical residency in Infectious Diseases, and Specialization in Tropical Medicine, at the University of São Paulo. She is also post- graduated in Health Services Administration from the University of Ribeirao Preto, and in Advanced Business Management for Health Services at the Armando Alvares Penteado Foundation. and Monitoring and Evaluation of Programs by the National School of Health at the Oswaldo Cruz Foundation. • Dr Nimalan ARINAMINPATHY (Nim Pathy), National of the United Kingdom Reader (Associate Professor) in Mathematical Epidemiology at Imperial College, London. Dr Nim Pathy applies mathematical and statistical tools to study the spread and control of infectious diseases, with a focus on human tuberculosis. He works closely with national TB programmes in high-burden countries, particularly India and Kenya. He was a Commissioner in the 2019 Lancet Commission on Tuberculosis. He also works with the WHO South-East Asian Regional Office (SEARO) on TB control priorities for the region, and has served on the SEARO regional advisory committee on multi-drug-resistant TB. Dr Pathy is a graduate of the University of Cambridge, St. Catharine’s College, with a BA Hons in Mathematics. He obtained his PhD in Applied Mathematics from the University of Oxford, Oxford Centre for Industrial and Applied Mathematics. He has collaborated on several important peer-reviewed publications on modelling of the tuberculosis epidemic. • Dr Grania BRIGDEN, National of the United Kingdom of Great Britain and Northern Ireland Director of the Department of TB at the International Union against TB and Lung Disease (The Union) Dr Brigden in her current role focuses on coordinating the development and expansion of The Union’s global work programmes for TB, HIV and other co-morbidities, and heads The Union’s Office in Generva. Ms Brigden has previously worked as Deputy Director for TB at The Union, as a Consultant at the Royal Free London- NHS Foundation Trust, as Lead of the Life Prize Project, and as TB and AMR Advisor for the Médicins Sans Frontières Access Campaign. She also has worked in Uganda with VSO (Voluntary Service Overseas), and in Banda Ache, Indonesia with Medic Global Sikhs. Ms Brigden studied medicine at University of Aberdeen and completed her specialist training in general and respiratory medicine in the North East Thames Deanery, London. She has authored/co-authored numerous scientific papers and publications. Dr Brigden serves on the Steering Committee of RESIST-TB, the Scientific Advisory Panel of the Medicines Patent Pool, and is Co-Chair of the TB Science Organizing Committee. She has served on WHO Task Forces on new TB drugs and on MDR-TB transition, as well as in guideline development groups. • Dr Glenda GRAY, National of South Africa President and CEO of the South African Medical Research Council In addition to her leadership role at the South African Medical Research Council, Dr Gray is Research Professor in Paediatrics at the University of the Witwatersrand, and Member (Professor) in the Vaccine & Infectious Disease Division at the Fred Hutch Cancer Research Center, in Seattle, WA; USA. Qualified as a Medical Doctor, specialising in Paediatrics, Dr Gray’s research career started in the field of preventing mother to child transmission of HIV-1 (PMTCT). Dr Gray collaborated in multi-country efforts to find short-course and affordable antiretroviral interventions for PMTCT.

Load more